Yuta Saito Selected Research

Integrin alpha3beta1

4/2010	Potentiation of cell invasion and matrix metalloproteinase production by alpha3beta1 integrin-mediated adhesion of gastric carcinoma cells to laminin-5.
3/2008	Changes in adhesive and migratory characteristics of hepatocellular carcinoma (HCC) cells induced by expression of alpha3beta1 integrin.
1/2005	Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuta Saito Research Topics

Disease

3	Retinopathy of Prematurity (Retrolental Fibroplasia) 04/2008 - 11/2006
2	Colorectal Neoplasms (Colorectal Cancer) 07/2016 - 01/2016
2	Retinal Neovascularization 09/2014 - 07/2007
2	Hepatocellular Carcinoma (Hepatoma) 03/2008 - 01/2005
1	Cataract (Cataracts) 07/2022
1	Glaucoma 07/2022
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 09/2021
1	Ocular Hypertension (Glaucoma, Suspect) 09/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Hallucinations (Hallucination) 01/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Retinal Vein Occlusion 01/2018
1	Macular Edema 01/2018
1	Inflammation (Inflammations) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Alcoholism (Alcohol Abuse) 01/2016
1	Neoplasms (Cancer) 03/2015
1	Pathologic Neovascularization 03/2015
1	Disease Progression 03/2015
1	Body Weight (Weight, Body) 09/2014
1	Rheumatoid Arthritis 05/2011
1	Epiretinal Membrane (Epiretinal Membranes) 08/2010
1	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2010
1	Carcinoma (Carcinomatosis) 04/2010
1	Neoplasm Metastasis (Metastasis) 03/2008
1	Corneal Neovascularization 02/2007
1	Weight Gain 11/2006

Drug/Important Bio-Agent (IBA)

4	Retinaldehyde (Retinal)IBA 09/2014 - 11/2006
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 04/2008
3	Oxygen (Dioxygen)IBA 03/2015 - 07/2007
3	Laminin (Merosin)IBA 04/2010 - 01/2005
3	Integrin alpha3beta1IBA 04/2010 - 01/2005
2	Pharmaceutical PreparationsIBA 07/2022 - 11/2006
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2010
2	Ethanol (Ethyl Alcohol)IBA 07/2016 - 01/2016
2	Apyrase (ATP Diphosphatase)IBA 09/2014 - 07/2007
2	KalininIBA 04/2010 - 03/2008
2	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2008 - 06/2007
2	adhesion receptorIBA 03/2008 - 01/2005
2	Protein Isoforms (Isoforms)IBA 03/2008 - 01/2005
1	Carteolol (Carteolol Hydrochloride)FDA LinkGeneric 09/2021
1	Latanoprost (Xalatan)FDA Link 09/2021
1	Timolol (Blocadren)FDA LinkGeneric 09/2021
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2020
1	Antipsychotic Agents (Antipsychotics)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 03/2015
1	calpastatinIBA 03/2015
1	CalpainIBA 03/2015
1	CytokinesIBA 03/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2015
1	Vascular Endothelial Growth Factor CIBA 03/2015
1	Janus KinasesIBA 03/2015
1	Neutralizing AntibodiesIBA 03/2015
1	Prednisolone (Predate)FDA LinkGeneric 05/2011
1	Biomarkers (Surrogate Marker)IBA 08/2010
1	PeriostinIBA 08/2010
1	LigandsIBA 04/2010
1	Matrix Metalloproteinases (MMPs)IBA 04/2010
1	TeaIBA 07/2007
1	AntioxidantsIBA 06/2007
1	NADP (NADPH)IBA 06/2007
1	acetovanillone (apocynin)IBA 06/2007
1	Oxidoreductases (Dehydrogenase)IBA 06/2007
1	Acetylcysteine (Siran)FDA LinkGeneric 06/2007
1	Lipid PeroxidesIBA 02/2007
1	linoleic acid hydroperoxideIBA 02/2007
1	A-3922IBA 02/2007
1	Integrin alpha3IBA 01/2005
1	Proto-Oncogene Proteins c-etsIBA 01/2005
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2005

Therapy/Procedure

1	Trabeculectomy (Trabeculoplasty) 07/2022
1	Injections 01/2020